Drug Trial Radar · NCT04888728
To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Aug 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Jun 30, 2021
Primary completion
Jul 12, 2021
Study completion Jul 27, 2021
Sponsor
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.Industry
- Sponsor type
- Industry
- First posted
- May 17, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 20 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
An open label, 2-part, one-sequence, 3-period study to evaluate drug-drug interactions between DWN12088 and nebivolol or Paroxetine in healthy volunteers
Conditions
- Idiopathic Pulmonary Fibrosis
Interventions
DWN12088Drug
Prolyl-tRNA synthetase (PRS) inhibitor
NebivololDrug
Nebivolol
ParoxetineDrug
Paroxetine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cmax of NebivololTime frame: Day 1, Day 2, Day 3, Day 6, Day 7, and Day 8
- AUCt of NebivololTime frame: Day 1, Day 2, Day 3, Day 6, Day 7, and Day 8
- Cmax of DWN12088Time frame: Day 1, Day 2, Day 3, Day 4, Day 9, Day 10, Day 11, and Day 12
- AUCt of DWN12088Time frame: Day 1, Day 2, Day 3, Day 4, Day 9, Day 10, Day 11, and Day 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Inje University Busan Paik Hospital
Busan, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.